(Total Views: 368)
Posted On: 04/08/2019 2:30:41 PM
Post# of 17

$MDGL News Article - Madrigal Pharmaceuticals to Present Additional Analyses of Data from The Phase 2 NASH Study with MGL-3196 (resmetirom) at The International Liver Congress(TM) 2019 https://marketwirenews.com/news-releases/madr...61760.html
My Twitter: WhyteStocks